Sildenafil citrate + Sildenafil citrate + Placebo + Sildenafil citrate
Phase 3Completed 0 watching 0 views this week📈 Rising
76
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Pulmonary Arterial Hypertension, Children
Conditions
Pulmonary Arterial Hypertension, Children
Trial Timeline
Aug 1, 2003 → Jun 1, 2008
NCT ID
NCT00159913About Sildenafil citrate + Sildenafil citrate + Placebo + Sildenafil citrate
Sildenafil citrate + Sildenafil citrate + Placebo + Sildenafil citrate is a phase 3 stage product being developed by Pfizer for Pulmonary Arterial Hypertension, Children. The current trial status is completed. This product is registered under clinical trial identifier NCT00159913. Target conditions include Pulmonary Arterial Hypertension, Children.
Hype Score Breakdown
Clinical
27
Activity
18
Company
9
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00159913 | Phase 3 | Completed |
Competing Products
20 competing products in Pulmonary Arterial Hypertension, Children